{"nct_id":"NCT02319044","title":"Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2015-04-15","start_date_type":"ACTUAL","primary_completion_date":"2016-09-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}